Skip to main content
KMB $110.39 -0.28%
KMB logo

KMB · Kimberly Clark Corp

Track KMB — free
$110.39 -0.31 (-0.28%) At close · Aug 14
Market Cap
$36.71B
Shares
332.58M
All earnings calls

Earnings call · FY2025 Q4

Kimberly Clark Corp Q4 FY2025 Earnings Call

Kimberly Clark Corp Q4 FY2025 Earnings Call

Concluded Jan 27, 2026 Audio replay
Jan 27, 2026 43:01 56 turns
Period
FY2025 Q4
Runtime
43:01
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Kimberly-Clark closed 2025 with an eighth consecutive quarter of volume-plus-mix growth, posting Q4 net sales of $4.1 billion (down 0.6%) with 2.1% organic sales growth and adjusted operating profit up 13.1% year-over-year, while announcing the pending acquisition of Kenvue.

Innovation pipeline 25 International / IPC growth 19 Productivity and cost discipline 13 Power and Care strategy 10 Volume plus mix growth 10 Kenview acquisition 9

Management tone

Confident

Net tone +58 · low hedging

Grounding quotes
  • “Our execution of Power and Care is driving strong results, even amidst a dynamic external environment.”
  • “We feel very well positioned for, you know, more volume and mix growth in 2026.”
  • “I'm more excited about our next three years innovation than what we've done in our past three.”
  • “We expect pressure on the consumer and a focus on value to persist.”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $4.08B -0.6% YoY
Diluted EPS $1.50 +11.9% YoY
Gross margin 35.9% +0.7 pp YoY
Net income $499.00M +11.6% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Eighth consecutive quarter of volume-plus-mix growth in Q4, with Q4 volume-plus-mix up 1.7% (3.6% on a two-year stack) and full-year North America volume-plus-mix up 2.1% in Q4 (4.1% on a two-year stack)
  • Q4 adjusted operating profit of $629 million, up 13.1% versus prior year, driven by strong productivity gains and lower planned marketing, R&D and general expenses
  • Q4 adjusted EPS of $1.86, up 24.0% versus prior year
  • Gained enterprise weighted share and delivered a second straight year of industry-leading productivity, with Q4 the strongest of the year
  • Strong international share momentum in focus markets: top six IPC markets up ~50 bps weighted share, China diapers +270 bps, Indonesia fem care ~+200 bps, Korea +60 bps, Australia +50 bps, Brazil +40 bps
  • Pending acquisition of Kenvue expected to compound momentum and shift the portfolio toward higher-growth, higher-margin personal care/health and wellness categories

Risks & pressure points

  • Q4 net sales of $4.1 billion declined 0.6% as organic sales growth of 2.1% was more than offset by a 2.5% decline from the exit of the US private label diaper business
  • Adjusted gross margin of 37.0% was flat versus prior year as strong productivity and volume growth were offset by unfavorable pricing net of cost inflation
  • Organic price was a 1.1% drag in Q4 due to planned price investments to enhance value propositions
  • Management expects continued consumer pressure and focus on value to persist into 2026
  • Q4 GAAP results included ~110 bps of 2024 Transformation Initiative charges in gross margin and ~$122 million of items management excludes from adjusted operating profit

Key moments

Jump directly to management's words in the synchronized transcript.

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Buybacks · derived
$1.00M
Dividend / share
$1.28
Full-screen source Call document